May 19, 2026 08:06AM
May 19, 2026 08:00AM
May 19, 2026 08:00AM
May 19, 2026 08:00AM
Jun 13, 2025 04:30PM
Sep 30, 2024 08:00AM
May 14, 2024 08:30AM InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
Feb 13, 2024 05:41PM
Sep 29, 2023 01:21PM
May 15, 2023 12:33PM
Feb 17, 2023 05:00PM
Jan 10, 2023 07:32AM
Jan 10, 2023 07:30AM
Nov 11, 2022 06:51PM InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update
Nov 11, 2022 06:51PM
Sep 23, 2022 12:29PM
Sep 23, 2022 12:29PM
Sep 8, 2022 02:09PM
Sep 8, 2022 02:08PM
Sep 8, 2022 02:08PM
May 13, 2022 07:30AM InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update
May 13, 2022 07:30AM
Mar 17, 2022 07:31AM
Mar 17, 2022 07:30AM
Mar 17, 2022 07:30AM
Feb 15, 2022 05:40AM
Feb 14, 2022 07:34PM
Feb 14, 2022 07:34PM InMed Pharmaceuticals Reports Second Quarter Fiscal 2022 Financial Results and Provides Business Update
Jan 5, 2022 07:30AM
Jan 5, 2022 07:30AM
Nov 10, 2021 07:30AM
Nov 10, 2021 07:30AM
Nov 3, 2021 07:32AM
Nov 3, 2021 07:30AM
Nov 3, 2021 07:30AM InMed Pharmaceuticals Files PCT Patent Application for Treating Neurodegenerative Disease Using a Rare Cannabinoid
Oct 13, 2021 04:30PM
Oct 13, 2021 04:30PM
Sep 24, 2021 07:30AM
Sep 24, 2021 07:30AM
Sep 17, 2021 07:30AM
Sep 17, 2021 07:30AM
Sep 13, 2021 07:32AM Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
Sep 13, 2021 07:31AM
Sep 13, 2021 07:30AM
Sep 13, 2021 07:30AM
Sep 7, 2021 04:04PM
Sep 2, 2021 08:35AM
Jun 29, 2021 07:03AM
Jun 29, 2021 07:00AM InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
Jun 29, 2021 07:00AM

1,156,279 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All